Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2014, Article ID 787256, 8 pages
http://dx.doi.org/10.1155/2014/787256
Research Article

Prognostic Value of AIMS65 Score in Cirrhotic Patients with Upper Gastrointestinal Bleeding

Department of Medicine, Bronx Lebanon Hospital Center, 1650 Selwyn Avenue, Suite No. 10C, Bronx, NY 10457, USA

Received 5 July 2014; Revised 1 December 2014; Accepted 2 December 2014; Published 22 December 2014

Academic Editor: Spiros D. Ladas

Copyright © 2014 Vinaya Gaduputi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Katschinski, R. Logan, J. Davies, G. Faulkner, J. Pearson, and M. Langman, “Prognostic factors in upper gastrointestinal bleeding,” Digestive Diseases and Sciences, vol. 39, no. 4, pp. 706–712, 1994. View at Publisher · View at Google Scholar · View at Scopus
  2. T. A. Rockall, R. F. A. Logan, H. B. Devlin, and T. C. Northfield, “Selection of patients for early discharge or outpatient care after acute upper gastrointestinal haemorrhage,” The Lancet, vol. 347, no. 9009, pp. 1138–1140, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. N. I. Church, H. J. Dallal, J. Masson et al., “Validity of the Rockall scoring system after endoscopic therapy for bleeding peptic ulcer: a prospective cohort study,” Gastrointestinal Endoscopy, vol. 63, no. 4, pp. 606–612, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. O. Blatchford, W. R. Murray, and M. Blatchford, “A risk score to predict need for treatment for upper-gastrointestinal haemorrhage,” The Lancet, vol. 356, no. 9238, pp. 1318–1321, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. F. D. Srygley, C. J. Gerardo, T. Tran, and D. A. Fisher, “Does this patient have a severe upper gastrointestinal bleed?” The Journal of the American Medical Association, vol. 307, no. 10, pp. 1072–1079, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. J. R. Saltzman, Y. P. Tabak, B. H. Hyett, X. Sun, A. C. Travis, and R. S. Johannes, “A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding,” Gastrointestinal Endoscopy, vol. 74, no. 6, pp. 1215–1224, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. B. H. Hyett, M. S. Abougergi, J. P. Charpentier et al., “The AIMS65 score compared with the Glasgow-Blatchford score in predicting outcomes in upper GI bleeding,” Gastrointestinal Endoscopy, vol. 77, no. 4, pp. 551–557, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. American College of Gastroenterology, “Can AIMS65 score predict the risk of rebleeding in patients with upper gastrointestinal bleeding?” Program No. P471, Annual Scientific Meeting Abstracts, American College of Gastroenterology, Las Vegas, Nev, USA, 2012. View at Google Scholar
  9. S. Chandra, “AIMS65 score predicts short-term mortality but not the need for intervention in acute upper GI bleeding,” Gastrointestinal Endoscopy, vol. 78, no. 2, pp. 381–382, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Nakamura, T. Matsumoto, H. Sugimori, M. Esaki, T. Kitazono, and M. Hashizume, “Emergency endoscopy for acute gastrointestinal bleeding: prognostic value of endoscopic hemostasis and the AIMS65 score in Japanese patients,” Digestive Endoscopy, vol. 26, no. 3, pp. 369–376, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. R. J. Groszmann, “Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences,” Hepatology, vol. 20, no. 5, pp. 1359–1363, 1994. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Ginès, G. Fernández-Esparrach, and V. Arroyo, “Ascites and renal functional abnormalities in cirrhosis. Pathogenesis and treatment,” Baillière's Clinical Gastroenterology, vol. 11, no. 2, pp. 365–385, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Leke, T. R. Silveira, T. D. C. Escobar, and A. Schousboe, “Expression of glutamate decarboxylase (GAD) mRNA in the brain of bile duct ligated rats serving as a model of hepatic encephalopathy,” Neurochemical Research, vol. 39, no. 3, pp. 605–611, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. O. A. Sergeeva, “GABAergic transmission in hepatic encephalopathy,” Archives of Biochemistry and Biophysics, vol. 536, no. 2, pp. 122–130, 2013. View at Publisher · View at Google Scholar · View at Scopus